Drug intelligence / Profile preview

TOP-M119

Development stage
Preclinical
Lead developer
Topadur Pharma
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Transdermal, Intradermal
01

Overview

TOP-M119 is a novel small molecule drug candidate developed for the treatment of alopecia, including androgenic alopecia and chemotherapy-induced hair loss. It acts as a dual-mode vasodilator by activating the cGMP-enzyme regulatory system, thereby increasing blood flow to hair follicles and supporting hair regrowth. Preclinical studies have demonstrated that TOP-M119 is significantly more potent than standard treatments such as minoxidil, with a faster onset of action and improved local tolerability. The drug has been formulated for topical application and can also be delivered via dissolving microneedle systems to enhance targeted delivery to hair follicles while minimizing systemic exposure. Development efforts are led by Topadur Pharma in collaboration with Oshen Holdings, focusing on both liquid topical formulations and intradermal sustained release systems.

Other names
M119M-119M 119

Beyond the preview

Go deeper on TOP-M119.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOP-M119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call